GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Agilon Health Inc (NYSE:AGL) » Definitions » Change In Receivables

Agilon Health (Agilon Health) Change In Receivables : $0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Agilon Health Change In Receivables?

Agilon Health's change in receivables for the quarter that ended in Dec. 2023 was $0 Mil. It means Agilon Health's Accounts Receivable stayed the same from Sep. 2023 to Dec. 2023 .

Agilon Health's change in receivables for the fiscal year that ended in Dec. 2023 was $-460 Mil. It means Agilon Health's Accounts Receivable increased by $460 Mil from Dec. 2022 to Dec. 2023 .

Agilon Health's Accounts Receivable for the quarter that ended in Dec. 2023 was $942 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Agilon Health's Days Sales Outstanding for the three months ended in Dec. 2023 was 105.46.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Agilon Health's liquidation value for the three months ended in Dec. 2023 was $115 Mil.


Agilon Health Change In Receivables Historical Data

The historical data trend for Agilon Health's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agilon Health Change In Receivables Chart

Agilon Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
-23.28 -59.38 -149.04 -204.17 -460.37

Agilon Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Agilon Health Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Agilon Health  (NYSE:AGL) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Agilon Health's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=942.461/815.504*91
=105.46

2. In Ben Graham's calculation of liquidation value, Agilon Health's accounts receivable are only considered to be worth 75% of book value:

Agilon Health's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=488.343-1079.845+0.75 * 942.461+0.5 * 0
=115

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Agilon Health Change In Receivables Related Terms

Thank you for viewing the detailed overview of Agilon Health's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Agilon Health (Agilon Health) Business Description

Traded in Other Exchanges
N/A
Address
6210 E. US Highway 290, Suite 450, Austin, TX, USA, 78723
Agilon Health Inc is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. The company enables physicians to create their own Medicare-centric globally capitated line of business.
Executives
Jeffrey A. Schwaneke director C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Steven Sell director, officer: CEO & President C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Benjamin Shaker officer: Chief Markets Officer C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Timothy Gertsch officer: Chief Accounting Officer C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Silvana Battaglia director 227 WASHINGTON STREET, CONSHOHOCKEN PA 19428
Cd&r Investment Associates Ix, Ltd. 10 percent owner MAPLES CORPORATE SERVICES LIMITED, UGLAND HOUSE, GRAND CAYMAN E9 KY101194
Veeral Desai officer: Chief Strategy & Dev. Officer C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Benjamin Kornitzer officer: Chief Med. & Quality Officer C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
John William Wulf director C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Diana Mckenzie director METLIFE, 200 PARK AVENUE, NEW YORK NY 10166
Priscilla Kasenchak officer: Chief Accounting Officer 1111 MARCUS AVENUE, LAKE SUCCESS NY 11042
Michael L Smith director C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Theodore Halkias officer: Chief Business Officer C/O AGILON HEALTH, INC., 1 WORLD TRADE CENTER, SUITE 2000, LONG BEACH CA 90831
Joan Danieley officer: Chief Administrative Officer C/O AGILON HEALTH, INC., 1 WORLD TRADE CENTER, SUITE 2000, LONG BEACH CA 90831
Glenn Sobotka officer: Chief Accounting Officer C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723